web analytics
halo therapeutics logo
  • Our Approach
  • Our Pipeline
  • Investors
  • Team
  • News
  • Key PUBLICATIONS
  • Contact
Menu
  • Our Approach
  • Our Pipeline
  • Investors
  • Team
  • News
  • Key PUBLICATIONS
  • Contact

Day: 8 November 2021

UK Approval Of Molnupiravir May Create New And More Dangerous Covid-19 Variants

As of this morning, British drug regulators have approved the Covid-19 antiviral drug molnupiravir for use in Covid-19 patients at risk for severe illness, making them the first public health officials to do so.

© 2021 Halo Therapeutics

  • Privacy Policy
  • Disclaimer
  • Sitemap
Menu
  • Privacy Policy
  • Disclaimer
  • Sitemap
Linkedin Twitter
  • Our Approach
  • Our Pipeline
  • Investors
  • Team
  • News
  • Key PUBLICATIONS
  • Contact